Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Comparing two ways to increase cancer screening among veterans

Compares two approaches to get veterans with liver or colon cancer risk screened.

Plain-language title generated from the registry record
Registry title: Getting To Implementation: Improving Cancer Screening for Veterans

Key facts

Where
Pittsburgh, United StatesSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for US military veterans in VA care who need screening for colon or liver cancer, and staff who work in these screening steps at VA sites.

Age
Veterans must be 18 or older. Veterans in the colon cancer group must be 45 or older. Providers must be 18 or older.
Sex
All sexes can join.
Disease stage
Liver cancer screening group: a diagnosis of cirrhosis in the medical record. Colon cancer screening group: a positive stool screening test in the last 18 months.
Biomarker or test result
Colon cancer group: a positive fecal immunochemical test (FIT) or other screening stool test in the last 18 months.

Main reasons for not taking part

  • Veterans under 18
  • Veterans not enrolled in the VA
  • Veterans with no VA visit in the last 18 months
  • Veterans expected to live less than 6 months (a hospice code)
  • Members of the study team

Read by machine on 12 November 2026.

Where in United States

  • VA Pittsburgh Healthcare SystemPittsburgh, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
University of Pittsburgh
Trial code
NCT06458998
Record updated
31 July 2026
Original description
Gastrointestinal cancers such as colon cancer and liver cancer cause many deaths in the US. Testing could catch these cancers early, helping people live longer. The goal of this study is to compare two different ways of getting more people tested for these cancers: 1) by directly reaching out to the people who need testing or 2) by helping providers fix issues that hold up testing.Read full original descriptionShow less

Getting To Implementation: Comparing the Effectiveness of Implementation Strategies to Improve Cancer Screening for Veterans

Gastrointestinal cancers such as colon cancer and liver cancer cause many deaths in the US. Testing could catch these cancers early, helping people live longer. The goal of this study is to compare two different ways of getting more people tested for these cancers: 1) by directly reaching out to the people who need testing or 2) by helping providers fix issues that hold up testing.

The main question it aims to answer is: how should healthcare systems go about choosing one or the other?

Researchers will look at cancer testing rates over time at sites that are trying these different approaches. They will also survey and interview participants from these sites.

Inclusion: Veterans:; ≥18 years of age; Enrolled in Veterans Health Administration (VA); Have ≥1 VA encounter in the prior 18 months; Hepatocellular cancer (HCC) screening subgroup: Diagnosis of cirrhosis in electronic medical record; Colorectal cancer (CRC) screening subgroup: ≥45 years of age, positive fecal immunochemical test (FIT) (or other screening stool test) in the last 18 months; Providers:; Healthcare provider or related staff at participating VA site or engaged in CRC or HCC screening pathways in an included VA site (e.g., scheduling); ≥18 years of age.

Exclusion: Veterans:; <18 years of age; Not enrolled in VA; No VA encounters in the prior 18 months; Limited life expectancy (< 6 months), defined as having a code for hospice; Providers:; Members of the study team will not participate, even if their sites are recruited.

ClinicalTrials.gov NCT06458998